Genetic Heterogeneity of HER2 Amplification and Telomere Shortening in Papillary Thyroid Carcinoma

about

HER2 Analysis in Sporadic Thyroid Cancer of Follicular Cell Origin Current Knowledge in Thyroid Cancer-From Bench to Bedside.

P2860

Q39120488-048F25D2-E61B-4680-8ECB-B5E4DC0D0D09 Q42340016-E50F090A-2EC5-4596-93B2-82C2119F830E

P2860

Genetic Heterogeneity of HER2 Amplification and Telomere Shortening in Papillary Thyroid Carcinoma

Item

http://www.wikidata.org/entity/Q37377544

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 21 October 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Genetic Heterogeneity of HER2 ...... in Papillary Thyroid Carcinoma

@en

Genetic Heterogeneity of HER2 ...... n Papillary Thyroid Carcinoma.

@nl

type

Item

label

Genetic Heterogeneity of HER2 ...... in Papillary Thyroid Carcinoma

@en

Genetic Heterogeneity of HER2 ...... n Papillary Thyroid Carcinoma.

@nl

prefLabel

Genetic Heterogeneity of HER2 ...... in Papillary Thyroid Carcinoma

@en

Genetic Heterogeneity of HER2 ...... n Papillary Thyroid Carcinoma.

@nl

P1476

Genetic Heterogeneity of HER2 ...... in Papillary Thyroid Carcinoma

@en

P2093

Daniela Virginia Frau

http://www.w3.org/2001/XMLSchema#string

Furio Pacini

http://www.w3.org/2001/XMLSchema#string

Paola Caria

http://www.w3.org/2001/XMLSchema#string

Roberta Vanni

http://www.w3.org/2001/XMLSchema#string

Silvia Cantara

http://www.w3.org/2001/XMLSchema#string

Tinuccia Dettori

http://www.w3.org/2001/XMLSchema#string

P2860

TERT promoter mutations in thyroid cancer

Progress in molecular-based management of differentiated thyroid cancer

The distinctive nature of HER2-positive breast cancers

HER2 status in colorectal cancer: its clinical significance and the relationship between HER2 gene amplification and expression

Telomere dysfunction triggers extensive DNA fragmentation and evolution of complex chromosome abnormalities in human malignant tumors.

Genetic Predisposition to Familial Nonmedullary Thyroid Cancer: An Update of Molecular Findings and State-of-the-Art Studies.

Human Epidermal Growth Factor Receptor 2 (HER2) in Cancers: Overexpression and Therapeutic Implications

Association between BRAF V600E mutation and recurrence of papillary thyroid cancer.

Prevalence, clinicopathologic features, and somatic genetic mutation profile in familial versus sporadic nonmedullary thyroid cancer.

HER2 expression in gastric and oesophageal cancer: a meta-analytic review

P31

scholarly article

P356

10.3390/IJMS17101759

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27775641

http://www.w3.org/2001/XMLSchema#string

P932

5085783

http://www.w3.org/2001/XMLSchema#string

Genetic Heterogeneity of HER2 Amplification and Telomere Shortening in Papillary Thyroid Carcinoma

about

P2860

P2860

Genetic Heterogeneity of HER2 Amplification and Telomere Shortening in Papillary Thyroid Carcinoma

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P407

P433

P478

P577

P698

P932